HII Replit-01, a Series of HII Replit, LLC
Raised
$3M
Investors
57
Min Invest
$25,000
AltStreet Analysis
·Generated from EDGAR primary sources
HII Replit-01, a Series of HII Replit, LLC is a Delaware-organized pooled investment fund filed on April 7, 2026, that has raised $2.6M from 57 investors under Regulation D exemptions 506(b) and 3(c)(1). The offering has a $25K minimum investment and is associated with the Hiive platform, which operates 69 related private equity entities. Christopher DeLap is listed as Executive Officer, and no first sale date was disclosed.
This private equity offering uses the standard 506(b) and 3(c)(1) exemption combination typical of private funds, with a $25K minimum investment representing an accessible entry point for accredited investors. The entity follows Hiive's established pattern of creating series-level SPVs for individual company investments, consistent with their platform model for syndicated access to venture-stage companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Christopher DeLap
Executive Officer · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
